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INTRODUCTION  
Some of the problems are overcome by producing 
control drug delivery -system which enhance the 
therapeutic efficacy of a given drug for obtain maximum 
therapeutic efficacy and minimum side effects it 
necessary to deliver the agent to the target tissue in the 
optimal amount. In a sustained controlled release 
fashion, there are various approaches in delivering a 
therapeutic substance to the target site. 
 Drug action can be improved by developing new drug 
delivery system, such as the mucoadhesive microsphere 
drug delivery system. These systems remain in close 
contact with the absorption tissue, the mucous 
membrane, releasing the drug at the action site leading to 
a bioavailability increase and both local and systemic 
effects 1. The oral route of drug administration 
constitutes the most convenient and preferred means of 
drug delivery to systemic circulation of body. However 
oral administration of most of the drugs in conventional 
dosage forms has short-term limitations due to their 
inability to restrain and localize the system at gastro-
intestinal tract. Microspheres are the carrier linked drug 
delivery system in which particle size is ranges from 1-
1000 μm range in diameter having a core of drug and  
outer layers of polymer as coating material. The success 
of these microspheres is limited due to their short 
residence time at site of absorption. It would, therefore 
be advantageous to have means for providing an intimate 
contact of the drug delivery system with the absorbing 
membrane. This can be achieved by coupling 
bioadhesion characteristics to microspheres and 
developing “mucoadhesive microspheres”. 
Mucoadhesive microspheres have advantages like 
efficient absorption and enhanced bioavailability of the 
drugs due to a high surface to volume ratio, a much more 
intimate contact with the mucus layer and specific 
targeting of drugs to the absorption site
 2
. 
MICROSPHERES 
Microspheres, as carrier for drug is one such approach 
which can be used in a sustained controlled release 
fashion 3. Microspheres are small spherical particles, 
with diameters in the micrometer range (typically 1 μm 
to 1000 μm). Microspheres are sometimes referred to as 
microparticles 4. 
Dosage forms that can precisely control the release rate 
sand target drugs to a specific body site have created 
enormous impact on the formulation and development of 
novel drug delivery system.  The objective of controlled 
release drug delivery includes two important aspects 
namely spatial placement and temporal delivery of drug. 
Spatial placement relates to targeting a drug to a specific 
organ or tissue, while temporal delivery refers to 
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controlling the rate of drug delivery to the target tissue. 
Variety of devices have been used for controlled release 
drug delivery, biodegradable polymer microspheres are 
one of the most common types and hold several 
advantages. Microspheres can encapsulate many types of 
drugs including small molecules, proteins, and nucleic 
acids and are easily administered through a syringe 
needle. They are generally biocompatible, can provide 
high bioavailability, and are capable of sustained release 
for long periods of time. 
MUCOADHESIVE MICROSPHERES  
Recent advances in polymer science and drug carrier 
technologies have promulgated the development of novel 
drug carriers such as mucoadhesive microspheres that 
have boosted the use of bioadhesion in the drug delivery 
5. 
Mucoadhesive microspheres include microparticles and 
microcapsules of 1 to 1000 μm in diameter consisting 
either entirely of mucoadhesive polymer or having an 
outer coating with adhesive property 6. Microspheres 
have the potential to be used for controlled as well as 
spatial drug delivery. Incorporating mucoadhesivenes to 
microspheres leads to efficient absorption and enhanced 
bioavailability of drug. Specific targeting of drug to the 
absorption site is achieved by using homing devices 
(ligand) like plant lactin, bacterial adhesion etc. on the 
surface of the microspheres. Mucoadhesive microspheres 
can be tailored to adhere to mucosal linings of GIT, thus 
offering the possibilities of localized as well as systemic 
absorption of drug in controlled manner 7, 8. 
MUCOADHESION 
Various mucoadhesive dosage forms such as discs, 
microspheres, and tablets have been prepared and 
reported by several research groups. mucoadhesive drug 
delivery systems are used to enhance drug absorption in 
a site-specific manner 9. mucoadhesion is defined as the 
interaction between a mucin surface and a syntheticor 
natural polymer 10. Mucoadhesion is defined as the 
interaction between a mucin surface and a synthetic or 
natural polymer .Mucoadhesion has been widely 
promoted as a way of achieving site-specific drug 
delivery through the incorporation of mucoadhesive 
hydrophilic polymers with in pharmaceutical 
formulations such as “microspheres” along with the 
active pharmaceutical ingredient (API). It is the reliable 
means to deliver the drug to the target site with 
specificity, if modified, and to maintain the desired 
concentration at the site of interest without untoward 
effects 11. Microspheres received much attention not only 
for prolonged release, but also for targeting of anticancer 
drugs to the tumour. In future by combining various 
other strategies, microspheres will find the central place 
in novel drug delivery, particularly in diseased cell 
sorting, diagnostics, gene & genetic materials, safe, 
targeted and effective in vivo delivery and supplements 
as miniature versions of diseased organ and tissues in the 
body 12. 
 
 
MECHANISM OF MUCOADHESION 
The mechanism of adhesion of certain macromolecules 
to the surface of a mucous tissue is not well understood 
yet. The mucoadhesive must spread over the substrate to 
initiate close contact and increase surface contact, 
promoting the diffusion of its chains within the mucus. 
Attraction and repulsion forces arise and, for a 
mucoadhesive to be successful, the attraction forces must 
dominate. Each step can be facilitated by the nature of 
the dosage form and how it is administered. For example, 
a partially hydrated polymer can be absorbed by the 
substrate because of the attraction by the surface water 13. 
The mechanism of mucoadhesion is generally divided 
into two steps: the contact stage and the consolidation 
stage. The first stage is characterized by the contact 
between the mucoadhesive and the mucus membrane, 
with spreading and swelling of the formulation, initiating 
its deep contact with the mucus layer 14.  
Theories of mucoadhesion: 
The phenomena of bioadhesion occur by a complex 
mechanism. Above theories have been proposed, which 
will explain the mechanism of bioadhesion 15,16,17.  
Electronic theory: Involves the formation of an electric 
double layer at the mucoadhesive interface by the 
transfer of electrons between the mucoadhesive polymer 
and the mucin glycoprotein network. For example: 
Interaction between positively charged polymers 
chitosan and negatively charged mucosal surface which 
becomes adhesive on hydration and provides an intimate 
contact between a dosage form and absorbing tissue.  
Wetting Theory: States that if the contact angle of 
liquids on the substrate surface is lower, then there is a 
greater affinity for the liquid to the substrate surface. If 
two such substrate surfaces are brought in contact with 
each other in the presence of the liquid, the liquid may 
act as an adhesive amongst the substrate surfaces.  
Adsorption Theory: According to this theory, after an 
initial contact between two surfaces, the material adheres 
because of surface force acting between the atoms in two 
surfaces. Two types of chemical bonds resulting from 
these forces can be distinguished as primary chemical 
bonds of covalent nature and Secondary chemical bonds 
having many different forces of attraction likes 
electrostatic forces, Vander Walls forces, hydrogen and 
hydrophobic bonds.  
Diffusion Theory of Mucoadhesion 
Diffusion theory describes that polymeric chains from 
the bioadhesive interpenetrate into glycoprotein mucin 
chains and reach a sufficient depth within the opposite 
matrix to allow formation of a semi-permanent bond 18. 
The process can be visualized from the point of initial 
contact. The existence of concentration gradients will 
drive the polymer chains of the bioadhesive into the 
mucus network and the glycoprotein mucin chains into 
the bioadhesive matrix until an equilibrium penetration 
depth is achieved. 
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ADVANTAGES OF MUCOADHESIVE 
MICROSPHERES DRUG DELIVERY SYSTEM  
 Mucoadhesive systems have three distinct advantages 
when compared to conventional dosage forms.  
1. Readily localized in the region applied to improve and 
enhance the bioavailability of drugs. E.g. testosterone & 
its esters, vasopressin, dopamine, insulin and gentamycin 
etc.  
2. Facilitate intimate contact of the formulation with 
underlying absorption surface. This allows modification 
of tissue permeability for absorption of macromolecules. 
e.g. peptides and proteins.  
3. Prolong residence time of the dosage form at the site 
of application and absorption to permit once or twice a 
day dosing 19. 
4. Offers an excellent route, for the systemic delivery of 
drugs with high first-pass metabolism, there by offering a 
greater bioavailability 20. 
5. Additionally significant cost reductions may be 
achieved and dose-related side effects may be reduced 
due to API localization at the disease site21. 
DISADVANTAGES OF MUCOADHESIVE 
MICROSPHERES DRUG DELIVERY SYSTEM 
1. The release from the formulations may get modified.  
2. The release rate may vary from a variety of factors 
like food and the rate of transit though gut, mucin 
turnover rate etc.  
3. Differences in the release rate can be found from one 
dose to another.  
4. Any loss of integrity in release pattern of the dosage 
form may lead to potential toxicity.  
5. These kinds of dosage forms cannot be crushed or 
chewed.  
TYPES OF MUCOADHESIVE POLYMERS 
First generation mucoadhesive polymers 
First-generation mucoadhesive polymers may be divided 
into three main sub-categories, namely: Anionic 
polymers, Cationic polymers and non-ionic polymers. 
Among these anionic and cationic polymers have been 
exhibits the greatest mucoadhesive strength 22.  
Anionic polymers 
Anionic polymers are the most widely employed 
mucoadhesive polymers within pharmaceutical 
formulation due to their high mucoadhesive functionality 
and low toxicity. These include alginates, carrageenan, 
poly(- acrylic acid) (PAA) and its weakly cross-linked 
derivatives and sodium carboxymethylcellulose 
(NaCMC). PAA and NaCMC possess excellent 
mucoadhesive characteristics due to the formation of 
strong hydrogen bonding interactions with mucin 23. 
 Polycarbophil and carbomer (Carbopol, PAA derivatives 
have been studied extensively as mucoadhesive 
platforms for drug delivery to the GI tract. 24,25 . 
Carbomers are cross-linked with allyl sucrose or 
allylpentaerythritol, whereas polycarbophil polymers are 
cross-linked with divinyl glycol. Both compounds have 
the same acrylic backbone but vary in their cross-link 
density that is often tailored to suit pharmaceutical or 
cosmetic performance. 
Cationic polymers 
Chitosan is a cationic polysaccharide, the most abundant 
polysaccharide in the world, next to cellulose 26. The 
most explored mucoadhesive polymers, chitosan is 
gaining increasing importance due to its good 
biocompatibility, biodegradability and due to their 
favourable toxicological 27.The linearity of chitosan 
molecules also ensures sufficient chain flexibility for 
interpenetration 28. Chitosan may provide improved drug 
delivery via mucoadhesive mechanism; it has also been 
shown to enhance drug absorption via the paracellular 
route through neutralization of fixed anionic sites within 
the tight junctions between mucosal cells 29, 30.  
Novel second-generation mucoadhesives polymers. 
Second generation includes lectins and thiolated 
polymers. 
 Lectin these are generally defined as proteins or 
glycoprotein complexes of non-immune origin that 
are able to bind sugars selectively in a non-covalent 
manner 31. Lectins are capable of attaching themselves to 
carbohydrates on the mucus or epithelial cell surface and 
have been extensively studied, notably for drug-targeting 
applications 32, 33. These second-generation bioadhesives 
not only provide for cellular binding, but also for 
subsequent endo- and transcytosis. 
Thiolated polymers, also designated thiomers, are 
hydrophilic macromolecules exhibiting free thiol groups 
on the polymeric backbone. Due to these functional 
groups, various features of polyacrylates and cellulose 
derivatives were strongly improved 34. The presence of 
thiol groups in the polymer allows the formation of 
stable covalents bonds with cysteine-rich subdomains of 
mucus glycoproteins leading to increased residence time 
and improved bioavailability 35. Other advantageous 
mucoadhesive properties of thiolated polymers include 
improved tensile strength, rapid swelling, and water 
uptake behavior. .e.g-various thiolated polymers include 
chitosan-thioglycolic acid,chitosan-thioethylamidine, 
alginate-cysteine. 
CHARACTERISTICS OF MATERIAL WHICH 
ARE USED FOR THE FORMULATION OF 
MUCOADHESIVE MICROSPHERES
 36
. 
1. The polymer and its degradation products should be 
nontoxic and should be non absorbable from the 
gastrointestinal tract 
2. It should be nonirritant to the mucus membrane 
3. It should preferably form a strong noncovalent bond 
with the mucin epithelial cell surfaces 
4. It should adhere quickly to most tissue and should 
possess some site specificity 
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5. It should allow easy incorporation of the drug and 
should offer no hindrance to its release 
6. The polymers must not decompose on storage or 
during shelf life of the dosage form 
7. The cost of polymer should not be high so that the 
prepared dosage form remains competitive 
METHODS OF PREPARATION OF 
MUCOADHESIVE MICROSPHERES: 
1. Emulsion cross-linking method. 
2. Single emulsion techniques. 
3. Ionotropic gelation. 
4. Phase inversion method. 
5. Spray drying and spray congealing method. 
6. Solvent removal method. 
7. Hot melt method. 
1. Emulsion cross- linking method 
It was described by Thanoo and associates. This method 
utilizes the reactive functional group of polymer to 
crosslink with aldehyde group of cross linking agent. In 
this method water-in-oil (w/o) emulsion was prepared by 
emulsifying the polymer aqueous solution in the oily 
phase. Aqueous droplets were stabilized using a suitable 
surfactant like span 80 or dioctyl sodium 
sulphosuccinate. The stable emulsion was cross linked 
by using an appropriate cross-linker like gluteraldehyde 
to harden the droplets. Microspheres were filtered and 
washed repeatedly with hexane or petroleum ether to 
remove traces of oils. They were finally washed with 
water to remove cross linkers and then dried at room 
temperature for 24h 37.  
2. Single Emulsion Technique 
38.  
The microspheres of natural polymers are prepared by 
single emulsion technique. The polymers and drug are 
dissolved or dispersed in aqueous medium followed by 
dispersion in organic medium e.g. oil, results in 
formation of globules, and then the dispersed globule are 
cross linked by either of heat or by using the chemical 
cross-linkers. The chemical cross-linkers used are 
formaldehyde, glutaraldehyde, diacid chloride etc. 
Ionotropic Gelation 
39
.  
Using this method Microspheres are formed by 
dissolving the gel-type polymers, such as alginate, in an 
aqueous solution followed by suspending the active 
ingredient in the mixture and extruding the solution 
through needle to produce micro droplets which fall into 
a hardening solution containing calcium chloride under 
stirring at low speed. Divalent calcium ions present in 
the hardening solution crosslink the polymer, forming 
gelled microspheres.  
Phase Inversion Method  
The method involves addition of drug into dilute 
polymeric solution, in methylene chloride; and resultant 
mixture is poured into an unstirred bath of strong non-
solvent, petroleum ether, in a ratio of 1: 100. 
Microspheres produced are then clarified, washed with 
petroleum ether and air dried 40. 
Spray Drying 
41, 42.
 
This method involves dissolving/dispersing of the drug 
into the polymer solution which is then spray dried. By 
this method the size of microspheres can be controlled by 
manipulating the rate of spraying, feeding rate of 
polymer drug solution, nozzle size, and the drying 
temperature. 
Solvent removal method 
It is a non-aqueous method of microencapsulation, also 
suitable for water labile polymers such as the 
polyanhydrides. Carino and co-workers used this method 
for preparing microspheres. In this method, drug was 
dispersed or dissolved in a solution of the selected 
polymer in a volatile organic solvent like methylene 
chloride. This mixture was then suspended in silicone oil 
containing Span 85 and methylene chloride. After 
pouring the polymer solution into silicone oil, petroleum 
ether was added and stirred until solvent was extracted 
into the oil solution. The resulting microspheres were 
then dried under vacuum 43. 
Hot melt method 
In this method, the polymer was first melted and then 
mixed with solid particles of the drug that had been 
sieved to less than 50 μm . The mixture was suspended in 
a non-miscible solvent (like silicone oil), continuously 
stirred, and heated to 5 °C above the melting point of the 
polymer. When the emulsion was stabilized it was left 
for cooling until the polymer particles solidified. The 
resulting microspheres were washed with petroleum 
ether. The main objective for developing this method 
was to develop a microencapsulation process suitable for 
the water labile polymers, e.g., polyanhydrides. 
Microspheres with diameter of 1-1000 μm could be 
obtained and the size distribution could be easily 
controlled by changing the stirring rate. The major 
limitation of this method is that it is not suitable for 
thermolabile substances 44. 
DRUG LOADING TECHNIQUES IN 
MICROSPHERES
 45
.  
The drugs are loaded in the microspheres principally 
using two methods i.e. during the preparation of the 
microsphere or after the preparation of the microsphere 
by incubating them with the drug solution. The active 
components may be loaded by means of the physical 
entrapment, chemical linkage and surface absorption. It 
was found that maximum of drug loading in 
microspheres may be achieved by incorporating the drug 
during the time of preparation but it may get affected by 
many other process variables like presence of additives, 
method of preparation, heat of polymerization, agitation 
intensity etc. The loading of drug after the preparation of 
microspheres may be achieved by incubating them with 
high concentration of the drug in a suitable solvent. Here 
drug may be loaded in the microspheres via penetration 
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or diffusion of the drug through the pores present in the 
microsphere as well as by absorption   
APPLICATIONS OF MUCOADHESIVE 
MICROSPHERES: 
1. Mucoadhesive microsphere is one potential strategy 
for prolonging GRT. Mucoadhesive microspheres 
interact with mucous of GIT and are considered to be 
localized or trapped at the adhesive site by retaining a 
dosage form at the site of action, or systemic delivery by 
retaining a formulation in intimate contact with the 
absorption site which may result in prolonged gastric 
residence time as well as improvement in intimacy of 
contact with underlying absorptive membrane to achieve 
better therapeutic performance of drugs.  
2. Vaccine delivery for treatment of diseases like 
hepatitis, influenza, pertusis, ricin toxoid, diphtheria, 
birth control. Microsphere in vaccine delivery have a 
specific advantage like improved antigenicity by 
adjuvant action, modulation of antigen release, 
stabilization of antigen . 
3. Mucoadhesive microspheres as a novel carrier system 
to improve drug delivery by various routes of 
administration like buccal, oral, nasal, ocular, vaginal 
and rectal, either for systemic or for local effects. 
4. Mucoadhesive microspheres are used as targeted drug 
delivery system for various diseases. Mucoadhesive 
microspheres are involved in various clinical as well as 
pharmaceutical aspects46.  
 
Literature review on mucoadhesive microspheres 
Sr.no Drug used Indication Polymer used Result Ref 
 
1 Nifidipine Anti- 
hypertensive 
 
 
HPMC, 
Carbapol 
Mucoadhesive microspheres of nifidipine 
showed good controlled release properties 
and polymer used showed good 
entrapment efficiency 
47 
2 Ramipril Hypertension 
Myocardial- 
infraction 
Chitosan, 
Ethylcellulose 
Mucoadhsive  microspheric preparation of 
Ramipril prolonged the 
Gastrointestinal residence time and slow 
release of drug 
48 
3 Repaglinide Antidiabetic EudragitRS100chitosan It has been concluded that drug loaded 
mucoadhesive microspheres are suitable 
delivery systems for Repaglinide 
49 
4 Cephalexin Treatment of 
respiratory 
tract infection 
Sodium alginate, 
Guargum 
Improved  bioavailability of cephalexin 
and decrease the frequency of dosage form 
administration  
50 
5 Simvastatin Hypolipidemic 
 
Carbopol 940P, sodium 
CMC, Guargum, HPMC, 
sodium alginate, ethyle 
cellulose, methyl 
cellulose, xanthan gum 
Mucoadhesive microspheres of 
simvastratin were prepared and drug 
release was diffusion controlled 
51 
6 Rantidine 
hydrochlorid
e 
Gastroretentiv
e 
Chitosan and 
sodiumcarboxy methyl 
Celluloe 
Mucoadhesive microspheres of rantidine 
hydrochloride were prepared 
52 
7 Amoxicillin Anti-
helicobactor 
pylori for 
gastric and 
duodenal ulcer 
Carboxyvinyl polymer Amoxicillin administration in the form of 
amoxicillin mucoadhesive microspheres 
more effectively cleared H.pylori than in 
the form of suspention. 
53 
8 Propanolol 
hydrochlorid
e 
hypertension Sodium carboxy methyl 
cellulose, carbopol 934P, 
HPMC 
It has been concluded that mucoadhesive 
microspheres  can successfully design for 
sustain  delivery of propanolol 
hydrochloride and improve patient 
compliance 
54 
9 Glipizide Anti diabetic Sodium alginate  By using sodium alginate mucoadhesive 
microspheres of glipizide should increase 
thelength of stay of glipizide for the 
treatment of diabetes. 
55 
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CONCLUSION: 
 In future by combining with various other strategies 
mucoadhesive microspheres can find the central place in 
novel drug delivery. Microsphere drug delivery system 
provides opportunities for designing new controlled and 
delayed released oral formulations. Variety of 
opportunities offered by microspheres like protection and 
masking, reduction in dissolution rate, spatial targeting 
of the active ingredient. This approach facilitates reduce 
drug concentration at the site other than target organ or 
tissue, delivery of small quantities of potent drugs and 
protection of labile compounds before and after 
administration. Microspheres are ideal targeting drug 
delivery system with high safety profile. 
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